InnovAge (NASDAQ:INNV) Issues Earnings Results

InnovAge (NASDAQ:INNVGet Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01, Yahoo Finance reports. InnovAge had a negative return on equity of 10.51% and a negative net margin of 4.16%. The firm had revenue of $199.40 million during the quarter, compared to the consensus estimate of $190.19 million. During the same quarter in the previous year, the business earned ($0.09) earnings per share. InnovAge updated its FY 2025 guidance to EPS.

InnovAge Price Performance

INNV stock opened at $5.78 on Thursday. The stock has a 50-day moving average price of $5.97 and a two-hundred day moving average price of $4.99. InnovAge has a 12-month low of $3.52 and a 12-month high of $7.64. The company has a current ratio of 1.25, a quick ratio of 1.25 and a debt-to-equity ratio of 0.25. The company has a market cap of $786.01 million, a PE ratio of -24.08 and a beta of 0.39.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Further Reading

Earnings History for InnovAge (NASDAQ:INNV)

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.